Red cell distribution width: A new predictor for chronic thromboembolic pulmonary hypertension after pulmonary embolism

Chronic Respiratory Disease

Volumn 11, Issue 2, 2014, Pages 73-81

  Abul, Yasin ^a   Ozsu, Savas ^a   Korkmaz, Ahmet ^b   Bulbul, Yilmaz ^a   Orem, Asim ^a   Ozlu, Tevfik ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

^b Rize Devlet Hastanesi   (Turkey)

Author keywords

chronic pulmonary diseases; Chronic thromboembolic pulmonary hypertension; predictors; pulmonary hypertension; red cell distribution width

Indexed keywords

ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; HEMATOLOGICAL PARAMETERS; HUMAN; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RED CELL DISTRIBUTION WIDTH; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; AREA UNDER THE CURVE; BLOOD; CHRONIC DISEASE; COMPLICATION; HYPERTENSION, PULMONARY; MEAN CORPUSCULAR VOLUME; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CHRONIC DISEASE; ERYTHROCYTE INDICES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; ROC CURVE;

EID: 84898967826     PISSN: 14799723     EISSN: 14799731     Source Type: Journal    
DOI: 10.1177/1479972314525057     Document Type: Article

References (40)

1. Dartevelle P, Fadel E, Mussot S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J. 2004 ; 23 (4). 637-648
2. Fedullo PF, Auger WR, Kerr KM, et al. Chronic thromboembolic pulmonary hypertension. N Engl J Med. 2001 ; 345 (20). 1465-1472
3. Miniati M, Monti S, Bottai M, et al. Survival and restoration of pulmonary perfusion in a long-term follow-up of patients after acute pulmonary embolism. Medicine (Baltimore). 2006 ; 85 (5). 253-262
4. Becattini C, Manina G, Busti C, et al. Bosentan for chronic thromboembolic pulmonary hypertension: findings from a systematic review and meta-analysis. Thromb Res. 2010 ; 126 (1). e51 - e56
5. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med. 2004 ; 350 (22). 2257-2264
6. Dentali F, Donadini M, Gianni M, et al. Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism. Thromb Res. 2009 ; 124 (3). 256-258
7. Korkmaz A, Ozlu T, Ozsu S, et al. Long-term outcomes in acute pulmonary thromboembolism: the incidence of chronic thromboembolic pulmonary hypertension and associated risk factors. Clin Appl Thromb Hemost. 2012 ; 18 (3). 281-288
8. Hampole CV, Mehrotra AK, Thenappan T, et al. Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension. Am J Cardiol. 2009 ; 104 (6). 868-872
9. Rhodes CJ, Wharton J, Howard LS, et al. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart. 2011 ; 97 (13). 1054-1060
10. Zorlu A, Bektasoglu G, Guven FM, et al. Usefulness of admission red cell distribution width as a predictor of early mortality in patients with acute pulmonary embolism. Am J Cardiol. 2012 ; 109 (1). 128-134
11. Ozsu S, Abul Y, Gunaydin S, et al. Prognostic value of red cell distribution width in patients with pulmonary embolism. Clin Appl Thromb Hemost. :
12. Montagnana M, Cervellin G, Meschi T, et al. The role of red blood cell distribution width in cardiovascular and thrombotic disorders. Clin Chem Lab Med. 2012 ; 50 (4). 635-641
13. Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: the task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J. 2009 ; 30 (20). 2493-2537
14. Galie N, Torbicki A, Barst R, et al. Guidelines on diagnosis and treatment of pulmonary arterial hypertension: the task force on diagnosis and treatment of pulmonary arterial hypertension of the European Society of Cardiology. Eur Heart J. 2004 ; 25 (24). 2243-2278
15. Auger WR, Kim NH, Kerr KM, et al. Chronic thromboembolic pulmonary hypertension. Clin Chest Med. 2007 ; 28 (1). 255-269
16. McGoon M, Gutterman D, Steen V, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004 ; 126 (1 Suppl). 14S - 34S
17. Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation. 1990 ; 81 (6). 1735-1743
18. Bonderman D, Skoro-Sajer N, Jakowitsch J, et al. Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation. 2007 ; 115 (16). 2153-2158
19. Humbert M. Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology. Eur Respir Rev. 2010 ; 19 (115). 59-63
20. Piazza G, Goldhaber SZ. Chronic thromboembolic pulmonary hypertension. N Engl J Med. 2011 ; 364 (4). 351-360
21. Becattini C, Agnelli G, Pesavento R, et al. Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism. Chest. 2006 ; 130 (1). 172-175
22. Bonderman D, Wilkens H, Wakounig S, et al. Risk factors for chronic thromboembolic pulmonary hypertension. Eur Respir J. 2009 ; 33 (2). 325-331
23. Bonderman D, Jakowitsch J, Adlbrecht C, et al. Medical conditions increasing the risk of chronic thromboembolic pulmonary hypertension. Thromb Haemost. 2005 ; 93 (3). 512-516
24. Lang IM, Pesavento R, Bonderman D, et al. Risk factors and basic mechanisms of CTEPH: a current understanding. Eur Respir J. 2012 ; 41: 462-468
25. Fox EA, Kahn SR. The relationship between inflammation and venous thrombosis. A systematic review of clinical studies. Thromb Haemost. 2005 ; 94 (2). 362-365
26. Esmon CT. Coagulation inhibitors in inflammation. Biochem Soc Trans. 2005 ; 33 (Pt 2). 401-405
27. Quarck R, Nawrot T, Meyns B, et al. C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension. J Am Coll Cardiol. 2009 ; 53 (14). 1211-1218
28. Anderson JL, Ronnow BS, Horne BD, et al. Usefulness of a complete blood count-derived risk score to predict incident mortality in patients with suspected cardiovascular disease. Am J Cardiol. 2007 ; 99 (2). 169-174
29. Tonelli M, Sacks F, Arnold M, et al. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008 ; 117 (2). 163-168
30. Rhodes CJ, Wharton J, Howard LS, et al. Red cell distribution width outperforms other potential circulating biomarkers in predicting survival in idiopathic pulmonary arterial hypertension. Heart. 2011 ; 97 (13). 1054-1060
31. Ozsu S, Abul Y, Gulsoy A, et al. Red cell distribution width in patients with obstructive sleep apnea syndrome. Lung. 2012 ; 190 (3). 319-326
32. Forhecz Z, Gombos T, Borgulya G, et al. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009 ; 158 (4). 659-666
33. Savale L, Tu L, Rideau D, et al. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice. Respir Res. 2009 ; 10: 6
34. Steiner MK, Syrkina OL, Kolliputi N, et al. Interleukin-6 overexpression induces pulmonary hypertension. Circ Res. 2009 ; 104 (2). 236-244
35. Wynants M, Quarck R, Ronisz A, et al. Effects of C-reactive protein on human pulmonary vascular cells in chronic thromboembolic pulmonary hypertension. Eur Respir J. 2012 ; 40 (4). 886-894
36. Felker GM, Allen LA, Pocock SJ, et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM program and the duke databank. J Am Coll Cardiol. 2007 ; 50 (1). 40-47
37. Oh J, Kang SM, Hong N, et al. Relation between red cell distribution width with echocardiographic parameters in patients with acute heart failure. J Card Fail. 2009 ; 15 (6). 517-522
38. Dabbah S, Hammerman H, Markiewicz W, et al. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction. Am J Cardiol. 2010 ; 105 (3). 312-317
39. Fukuta H, Ohte N, Mukai S, et al. Elevated plasma levels of B-type natriuretic peptide but not C-reactive protein are associated with higher red cell distribution width in patients with coronary artery disease. Int Heart J. 2009 ; 50 (3). 301-312
40. Perlstein TS, Weuve J, Pfeffer MA, et al. Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med. 2009 ; 169 (6). 588-594